So, if the levels of Acrp30 will be increased in the circulation then the insulin sensitivity can be increased and blood glucose levels (Table 3) can be easily managed which will make Acrp30 a potential novel target for the treatment of diabetes mellitus. The gene discussed is ADIPOQ; the disease is diabetes mellitus.